Dipeptidyl peptidase 4-inhibitor treatment was associated with a reduced incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of 115 randomized controlled trials with 121961 participantsZonglin Li, Linong Ji, Fang Lv et al.|Expert Opinion on Investigational Drugs|2022Cited by 11
Trends in baseline HbA1c and body-mass index in randomised placebo-controlled trials of type 2 diabetes from 1987 to 2022: a systematic review and meta-analysisSuiyuan Hu, Linong Ji, Fang Lv et al.|EClinicalMedicine|2023Cited by 8
Indirect comparison of efficacy and safety of chiglitazar and thiazolidinedione in patients with type 2 diabetes: A meta-analysisChu Lin, Linong Ji, Fang Lv et al.|World Journal of Diabetes|2023Cited by 8
Regional, age-specific and sex-specific trends in the prevalence of overweight or obesity in type 1 diabetes from 1980 to 2020: a meta-analysis of 78 observational studies with 650,265 participantsLinong Ji, Fang Lv, Xiaoling Cai et al.|Diabetes Research and Clinical Practice|2025Cited by 3